Hormone replacement therapy in postmenopausal women
- 1 August 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 188 (2) , 136-149
- https://doi.org/10.1016/j.amjsurg.2003.12.063
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studiesInternational Journal of Cancer, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary ReportGynecologic Oncology, 1996
- Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cellsMolecular and Cellular Endocrinology, 1994
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980